Amelioration of oxidative damage parameters by carvacrol on methanol-induced liver injury in rats

ArticleAçık Erişim

Özet

The methanol metabolite that causes hepatotoxicity is formic acid, generating reactive oxygen radical formation and cell damage. Carvacrol is an antioxidant monoterpenic phenol produced from Thymus vulgaris. This study aimed to investigate the effects of carvacrol on methanol-induced oxidative liver damage in rats. Eighteen rats were divided into three groups. Methotrexate was administered orally for 7 days to methotrexate+methanol (MTM) and methotrexate+methanol+carvacrol (MMC) groups. Methotrexate was given before methanol to cause methanol poisoning. Distilled water was given to the healthy group (HG) as a solvent. At the end of the 7th day, 20% methanol was administered orally at a dose of 3 g/kg to the MTM and MMC groups. Four hours after methanol administration, 50 mg/kg carvacrol was injected intraperitoneally into the MMC group. Animals were sacrificed 8 h after carvacrol injection. Biochemical markers were studied in the excised liver tissue and blood serum samples, and histopathological evaluations were made. Severe hemorrhage, hydropic degeneration, pycnosis, and mononuclear cell infiltration were observed in the liver of the MTM group. Additionally, the levels of malondialdehyde (MDA), total oxidant status (TOS), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were significantly higher, and total glutathione (tGSH) and total antioxidant status (TAS) were significantly lower in the MTM group compared to HG (P<0.001). Carvacrol prevented the increase in MDA, TOS, ALT and AST levels with methanol and the decrease in tGSH and TAS levels (P<0.001), and alleviated the histopathological damage. Carvacrol may be useful in the treatment of methanol-induced liver damage. © 2022 Japanese Association for Laboratory Animal Science.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12648Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1538/expanim.21-0143Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorGursul, Cebrail
dc.contributor.authorOzcicek, Adalet
dc.contributor.authorOzkaraca, Mustafa
dc.contributor.authorMendil, Ali Sefa
dc.contributor.authorCoban, Taha Abdulkadir
dc.contributor.authorArslan, Aynur
dc.contributor.authorOzcicek, Fatih
dc.contributor.authorSuleyman, Halis
dc.date.accessioned2026-10-18T20:27:31.583868778Z
dc.date.available2026-10-18T20:27:31.583868778Z
dc.date.issued2022
dc.description.abstractThe methanol metabolite that causes hepatotoxicity is formic acid, generating reactive oxygen radical formation and cell damage. Carvacrol is an antioxidant monoterpenic phenol produced from Thymus vulgaris. This study aimed to investigate the effects of carvacrol on methanol-induced oxidative liver damage in rats. Eighteen rats were divided into three groups. Methotrexate was administered orally for 7 days to methotrexate+methanol (MTM) and methotrexate+methanol+carvacrol (MMC) groups. Methotrexate was given before methanol to cause methanol poisoning. Distilled water was given to the healthy group (HG) as a solvent. At the end of the 7th day, 20% methanol was administered orally at a dose of 3 g/kg to the MTM and MMC groups. Four hours after methanol administration, 50 mg/kg carvacrol was injected intraperitoneally into the MMC group. Animals were sacrificed 8 h after carvacrol injection. Biochemical markers were studied in the excised liver tissue and blood serum samples, and histopathological evaluations were made. Severe hemorrhage, hydropic degeneration, pycnosis, and mononuclear cell infiltration were observed in the liver of the MTM group. Additionally, the levels of malondialdehyde (MDA), total oxidant status (TOS), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were significantly higher, and total glutathione (tGSH) and total antioxidant status (TAS) were significantly lower in the MTM group compared to HG (P<0.001). Carvacrol prevented the increase in MDA, TOS, ALT and AST levels with methanol and the decrease in tGSH and TAS levels (P<0.001), and alleviated the histopathological damage. Carvacrol may be useful in the treatment of methanol-induced liver damage. © 2022 Japanese Association for Laboratory Animal Science.
dc.identifier.doi10.1538/expanim.21-0143
dc.identifier.eissn1881-7122
dc.identifier.endpage230
dc.identifier.issn1341-1357
dc.identifier.issue2
dc.identifier.pmcidPMC9130043
dc.identifier.pmid34911876
dc.identifier.scopus2-s2.0-85131043601
dc.identifier.startpage224
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12648
dc.identifier.volume71
dc.identifier.wosWOS:000800821300011
dc.language.isoen
dc.publisherInternational Press Editing Centre Incorporation
dc.relation.ispartofExperimental Animals
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectcarvacrol
dc.subjectexperimental models
dc.subjectliver injury
dc.subjectmethanol
dc.subjectoxidative damage
dc.subjectalanine aminotransferase
dc.subjectaspartate aminotransferase
dc.subjectdistilled water
dc.subjectformic acid
dc.subjectglutathione
dc.subjectmalate dehydrogenase
dc.subjectmalonaldehyde
dc.subjectmethotrexate
dc.subjectthiobarbituric acid
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectautopsy
dc.subjectbleeding
dc.subjectblood sampling
dc.subjectcell infiltration
dc.subjectcontrolled study
dc.subjectexperimental liver injury
dc.subjectfollow up
dc.subjecthistopathology
dc.subjectliver tissue
dc.subjectmale
dc.subjectmethanol poisoning
dc.subjectmethanol-induced liver injury
dc.titleAmelioration of oxidative damage parameters by carvacrol on methanol-induced liver injury in rats
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus11
rdl.citation.wos9
rdl.departmentDepartment of Physiology, Faculty of Medicine, Erzincan Binali Yildirim University, Basbaglar Street, 24030, Erzincan, Turkey. | Department of Internal Medicine, Faculty of Medicine, Erzincan Binali Yildirim University, Basbaglar Street, 24030, Erzincan, Turkey. | Department of Clinical Biochemistry, Faculty of Medicine, Erzincan Binali Yildirim University, Basbaglar Street, 24030, Erzincan, Turkey. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Basbaglar Street, 24030, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)